Encompass Health Corporation Interest Expense Nonoperating
Encompass Health Corporation (EHC) reported Interest Expense Nonoperating of $32.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-07
- Encompass Health Corporation interest expense nonoperating for the quarter ending 2026-06-30 was $32.80M, a 7.89% increase year-over-year.
- Encompass Health Corporation interest expense nonoperating for the quarter ending 2026-03-31 was $31.80M, a 0.00% change year-over-year.
- Encompass Health Corporation interest expense nonoperating for the quarter ending 2025-12-31 was $30.20M, a 8.48% decline year-over-year.
- Encompass Health Corporation interest expense nonoperating for the quarter ending 2025-09-30 was $30.80M, a 11.75% decline year-over-year.
- Encompass Health Corporation interest expense nonoperating for fiscal 2025 was $123.20M, a 10.33% decline from fiscal 2024.
- Encompass Health Corporation interest expense nonoperating for fiscal 2024 was $137.40M, a 4.25% decline from fiscal 2023.
- Encompass Health Corporation interest expense nonoperating for fiscal 2023 was $143.50M, a 18.33% decline from fiscal 2022.
- Encompass Health Corporation interest expense nonoperating for fiscal 2022 was $175.70M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $32.80M 10-Q · filed 2026-08-07 | $64.60M 10-Q · filed 2026-08-07 | $94.80M derived: sum of 3 quarters · filed 2026-08-07 | $125.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $31.80M 10-Q · filed 2026-05-01 | $62.00M derived: sum of 2 quarters · filed 2026-05-01 | $92.80M derived: sum of 3 quarters · filed 2026-05-01 | $123.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $30.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $61.00M derived: sum of 2 quarters · filed 2026-02-26 | $91.40M derived: sum of 3 quarters · filed 2026-08-07 | $123.20M 10-K · filed 2026-02-26 |
| 2025-09-30 | $30.80M 10-Q · filed 2025-10-31 | $61.20M derived: sum of 2 quarters · filed 2026-08-07 | $93.00M 10-Q · filed 2025-10-31 | $126.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $30.40M 10-Q · filed 2026-08-07 | $62.20M 10-Q · filed 2026-08-07 | $95.20M derived: sum of 3 quarters · filed 2026-08-07 | $130.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $31.80M 10-Q · filed 2026-05-01 | $64.80M derived: sum of 2 quarters · filed 2026-05-01 | $99.70M derived: sum of 3 quarters · filed 2026-05-01 | $134.00M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $67.90M derived: sum of 2 quarters · filed 2026-02-26 | $102.20M derived: sum of 3 quarters · filed 2026-02-26 | $137.40M 10-K · filed 2026-02-26 |
| 2024-09-30 | $34.90M 10-Q · filed 2025-10-31 | $69.20M derived: sum of 2 quarters · filed 2025-10-31 | $104.40M 10-Q · filed 2025-10-31 | $139.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $34.30M 10-Q · filed 2025-08-06 | $69.50M 10-Q · filed 2025-08-06 | $104.40M derived: sum of 3 quarters · filed 2026-02-26 | $140.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $35.20M 10-Q · filed 2025-05-01 | $70.10M derived: sum of 2 quarters · filed 2026-02-26 | $106.00M derived: sum of 3 quarters · filed 2026-02-26 | $142.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $34.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $70.80M derived: sum of 2 quarters · filed 2026-02-26 | $107.10M derived: sum of 3 quarters · filed 2026-02-26 | $143.50M 10-K · filed 2026-02-26 |
| 2023-09-30 | $35.90M 10-Q · filed 2024-11-01 | $72.20M derived: sum of 2 quarters · filed 2024-11-01 | $108.60M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $36.30M 10-Q · filed 2024-08-06 | $72.70M 10-Q · filed 2024-08-06 | ||
| 2022-12-31 | $175.70M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |